These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 10522876)

  • 1. The tau gene A0 allele and progressive supranuclear palsy.
    Hoenicka J; Pérez M; Pérez-Tur J; Barabash A; Godoy M; Vidal L; Astarloa R; Avila J; Nygaard T; de Yébenes JG
    Neurology; 1999 Oct; 53(6):1219-25. PubMed ID: 10522876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significant changes in the tau A0 and A3 alleles in progressive supranuclear palsy and improved genotyping by silver detection.
    Oliva R; Tolosa E; Ezquerra M; Molinuevo JL; Valldeoriola F; Burguera J; Calopa M; Villa M; Ballesta F
    Arch Neurol; 1998 Aug; 55(8):1122-4. PubMed ID: 9708963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tau gene A0 polymorphism in progressive supranuclear palsy and related neurodegenerative diseases.
    Morris HR; Janssen JC; Bandmann O; Daniel SE; Rossor MN; Lees AJ; Wood NW
    J Neurol Neurosurg Psychiatry; 1999 May; 66(5):665-7. PubMed ID: 10209184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms in the tau gene in sporadic frontotemporal dementia and other neurodegenerative disorders.
    Panegyres PK; Zafiris-Toufexis K
    Eur J Neurol; 2002 Sep; 9(5):485-9. PubMed ID: 12220379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in a dinucleotide repeat polymorphism in the tau gene between Caucasian and Japanese populations: implication for progressive supranuclear palsy.
    Conrad C; Amano N; Andreadis A; Xia Y; Namekataf K; Oyama F; Ikeda K; Wakabayashi K; Takahashi H; Thal LJ; Katzman R; Shackelford DA; Matsushita M; Masliah E; Sawa A
    Neurosci Lett; 1998 Jul; 250(2):135-7. PubMed ID: 9697937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive supranuclear palsy: earlier age of onset in patients with the tau protein A0/A0 genotype.
    Molinuevo JL; Valldeoriola F; Alegret M; Oliva R; Tolosa E
    J Neurol; 2000 Mar; 247(3):206-8. PubMed ID: 10787116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further extension of the H1 haplotype associated with progressive supranuclear palsy.
    Pastor P; Ezquerra M; Tolosa E; Muñoz E; Martí MJ; Valldeoriola F; Molinuevo JL; Calopa M; Oliva R
    Mov Disord; 2002 May; 17(3):550-6. PubMed ID: 12112206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The tau A0 allele in Parkinson's disease.
    Golbe LI; Lazzarini AM; Spychala JR; Johnson WG; Stenroos ES; Mark MH; Sage JI
    Mov Disord; 2001 May; 16(3):442-7. PubMed ID: 11391737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct genetic evidence for involvement of tau in progressive supranuclear palsy. European Study Group on Atypical Parkinsonism Consortium.
    Bennett P; Bonifati V; Bonuccelli U; Colosimo C; De Mari M; Fabbrini G; Marconi R; Meco G; Nicholl DJ; Stocchi F; Vanacore N; Vieregge P; Williams AC
    Neurology; 1998 Oct; 51(4):982-5. PubMed ID: 9781517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
    Kowalska A; Jamrozik Z; Kwieciński H
    Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of tau in familial and sporadic progressive supranuclear palsy.
    Morris HR; Katzenschlager R; Janssen JC; Brown JM; Ozansoy M; Quinn N; Revesz T; Rossor MN; Daniel SE; Wood NW; Lees AJ
    J Neurol Neurosurg Psychiatry; 2002 Mar; 72(3):388-90. PubMed ID: 11861703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear gaze palsy is in linkage disequilibrium with the tau and not the alpha-synuclein gene.
    Higgins JJ; Litvan I; Pho LT; Li W; Nee LE
    Neurology; 1998 Jan; 50(1):270-3. PubMed ID: 9443491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel polymorphism in the promoter region of the tau gene highly associated to progressive supranuclear palsy in humans.
    Ezquerra M; Pastor P; Valldeoriola F; Molinuevo JL; Blesa R; Tolosa E; Oliva R
    Neurosci Lett; 1999 Nov; 275(3):183-6. PubMed ID: 10580705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An extended 5'-tau susceptibility haplotype in progressive supranuclear palsy.
    Higgins JJ; Golbe LI; De Biase A; Jankovic J; Factor SA; Adler RL
    Neurology; 2000 Nov; 55(9):1364-7. PubMed ID: 11087782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational analysis of the tau gene in progressive supranuclear palsy.
    Higgins JJ; Adler RL; Loveless JM
    Neurology; 1999 Oct; 53(7):1421-4. PubMed ID: 10534245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increase in the relative expression of tau with four microtubule binding repeat regions in frontotemporal lobar degeneration and progressive supranuclear palsy brains.
    Ingelsson M; Ramasamy K; Russ C; Freeman SH; Orne J; Raju S; Matsui T; Growdon JH; Frosch MP; Ghetti B; Brown RH; Irizarry MC; Hyman BT
    Acta Neuropathol; 2007 Nov; 114(5):471-9. PubMed ID: 17721707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A lack of the R406W tau mutation in progressive supranuclear palsy and corticobasal degeneration.
    Higgins JJ; Litvan I; Nee LE; Loveless JM
    Neurology; 1999 Jan; 52(2):404-6. PubMed ID: 9932968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parkin polymorphisms in progressive supranuclear palsy.
    Ros R; Ampuero I; García de Yébenes J
    J Neurol Sci; 2008 May; 268(1-2):176-8. PubMed ID: 18022644
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive supranuclear palsy pathology caused by a novel silent mutation in exon 10 of the tau gene: expansion of the disease phenotype caused by tau gene mutations.
    Stanford PM; Halliday GM; Brooks WS; Kwok JB; Storey CE; Creasey H; Morris JG; Fulham MJ; Schofield PR
    Brain; 2000 May; 123 ( Pt 5)():880-93. PubMed ID: 10775534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.